Skip to content

Repligen RGEN Interest coverage

Interest coverage at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.6×+0.7×
Danaher logo
DanaherDHR
18.6×+1.7×
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-6.5×+0.4×
Agilent Technologies logo
Agilent TechnologiesA
14.8×+2.0×
TEC
Bio-TechneTECH
16.7×-0.8×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
22.7×+17.6×

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$8.19B+22.7%
Enterprise value$8.3B+35.3%
P/E159.4×
P/S11.2×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

Based on trailing twelve months.

The official record: Repligen’s 10-Q, filed November 18, 2024, on SEC EDGAR. View the filing →

Ask your AI about Repligen's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's interest coverage?
Repligen (RGEN) reported interest coverage of 0.6× in Q3 2024.
How has Repligen's interest coverage changed year-over-year?
Repligen's interest coverage decreased by 99.3% year-over-year, from 85.3× to 0.6×.
What is the long-term trend for Repligen's interest coverage?
Over 3 years (2020 to 2023), Repligen's interest coverage has grown at a 65.3% compound annual growth rate (CAGR), from 6.5× to 29.3×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.